Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Dosage Regimen: Individualization

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Psychedelica bij de behandeling van psychiatrische aandoeningen anno 2025].

Tijdschrift voor psychiatrie·2025

Same author

[The future of the Belgian psychiatric patient according to the WPA-Lancet Commission].

Tijdschrift voor psychiatrie·2025

Same author

Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper.

European psychiatry : the journal of the Association of European Psychiatrists·2025

Same author

[Police and judicial actors on complex mental health care needs and judicial protection measures].

Tijdschrift voor psychiatrie·2024

Same author

Associations between genetic liabilities to smoking behavior and schizophrenia symptoms in patients with a psychotic disorder, their siblings and healthy controls.

Psychiatry research·2023

Same author

[Transcranial direct current stimulation in substance use disorders: an update].

Tijdschrift voor psychiatrie·2022

Search research articles

Related Experiment Video

Updated: May 5, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

[Developments in pharmacotherapy: personalised pharmacotherapy?].

G Dom, W van den Brink

Tijdschrift Voor Psychiatrie

|November 19, 2013

Summary

Personalized pharmacotherapy for addiction is emerging. Tailoring treatments to addiction stages and patient profiles, including genetics, shows promise for improving treatment effectiveness beyond current limitations.

Area of Science:

Addiction medicine
Pharmacology
Genetics

Context:

Pharmacological treatments for addictive disorders have limited effect sizes.
Many patients do not benefit from current pharmacotherapy.
Developing strategies to enhance treatment effectiveness is crucial.

Purpose:

To develop strategies for enhancing the effectiveness of pharmacotherapy for addiction.
To match pharmacological interventions to specific stages of addiction.
To explore patient characteristics for personalized medication.

Summary:

A literature review utilized a staging and profiling model to match pharmacotherapy to addiction stages.
Interventions can be tailored to reduce impulsivity, craving, and substance abuse in early stages, and negative effects and craving in later stages.

More Related Videos

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Related Experiment Videos

Last Updated: May 5, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Endophenotypical and genetic characteristics show promise for personalized pharmacotherapy, though validation is needed.

Impact:

Personalized medication for addiction is not yet a reality, but promising developments exist.
Pharmacogenetics offers favorable short-term prospects for tailored addiction treatment.
A staging and profiling model provides a framework for advancing addiction pharmacotherapy.